Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”

Harmen R. Moes; Erik Buskens; Teus van Laar

doi:10.1186/s12883-024-03692-2

Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”

Harmen R. Moes^*, Erik Buskens, Teus van Laar

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Citation (Scopus)

12 Downloads (Pure)

Abstract

The 5-2-1 criteria are intended to help general neurologists identify patients with advanced Parkinson’s disease who may benefit from treatment optimisation, such as with a device-aided therapy. Although the 5-2-1 criteria claim to address an unmet need, we urge readers to cautiously interpret the results of this validation study.

Original language	English
Article number	189
Number of pages	4
Journal	BMC NEUROLOGY
Volume	24
Issue number	1
DOIs	https://doi.org/10.1186/s12883-024-03692-2
Publication status	Published - Dec-2024

Keywords

5-2-1 criteria
Advanced Parkinson’s disease
Device-aided therapy
Positive predictive value
Validation

Access to Document

10.1186/s12883-024-03692-2Licence: CC BY

Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease?Final publisher's version, 781 KBLicence: CC BY

Handle.net

Persistent link

Cite this

@article{8e83f40d122a4e4ba7b03c8692e3482b,

title = "Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson{\textquoteright}s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”",

abstract = "The 5-2-1 criteria are intended to help general neurologists identify patients with advanced Parkinson{\textquoteright}s disease who may benefit from treatment optimisation, such as with a device-aided therapy. Although the 5-2-1 criteria claim to address an unmet need, we urge readers to cautiously interpret the results of this validation study.",

keywords = "5-2-1 criteria, Advanced Parkinson{\textquoteright}s disease, Device-aided therapy, Positive predictive value, Validation",

author = "Moes, {Harmen R.} and Erik Buskens and {van Laar}, Teus",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = dec,

doi = "10.1186/s12883-024-03692-2",

language = "English",

volume = "24",

journal = "BMC NEUROLOGY",

issn = "1471-2377",

publisher = "BioMed Central Ltd.",

number = "1",

}

Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”. / Moes, Harmen R.; Buskens, Erik ; van Laar, Teus.
In: BMC NEUROLOGY, Vol. 24, No. 1, 189, 12.2024.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”

AU - Moes, Harmen R.

AU - Buskens, Erik

AU - van Laar, Teus

N1 - Publisher Copyright: © The Author(s) 2024.

PY - 2024/12

Y1 - 2024/12

N2 - The 5-2-1 criteria are intended to help general neurologists identify patients with advanced Parkinson’s disease who may benefit from treatment optimisation, such as with a device-aided therapy. Although the 5-2-1 criteria claim to address an unmet need, we urge readers to cautiously interpret the results of this validation study.

AB - The 5-2-1 criteria are intended to help general neurologists identify patients with advanced Parkinson’s disease who may benefit from treatment optimisation, such as with a device-aided therapy. Although the 5-2-1 criteria claim to address an unmet need, we urge readers to cautiously interpret the results of this validation study.

KW - 5-2-1 criteria

KW - Advanced Parkinson’s disease

KW - Device-aided therapy

KW - Positive predictive value

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=85195353656&partnerID=8YFLogxK

U2 - 10.1186/s12883-024-03692-2

DO - 10.1186/s12883-024-03692-2

M3 - Comment/Letter to the editor

C2 - 38840056

AN - SCOPUS:85195353656

SN - 1471-2377

VL - 24

JO - BMC NEUROLOGY

JF - BMC NEUROLOGY

IS - 1

M1 - 189

ER -

Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”

Abstract

Keywords

Access to Document

Handle.net

Other files and links

Fingerprint

Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2)

Cite this